-
Women now rely on contraception in such new forms as a transdermal patch and a vaginal ring. In fact, about 75% of readers participating in the 2003 Contraceptive Technology Update Contraception Survey say their facilities are offering these birth control options. What if women could get reliable birth control from a spray-on application to the skin?
-
A pill designed to prevent unintended pregnancy and birth defects is moving closer to commercial reality following a Food and Drug Administration (FDA) advisory committees unanimous vote to back such a combination product.
-
As you check the chart of your next patient, you note she is scheduled for her quarterly injection of depot medroxyprogesterone acetate (DMPA, Depo-Provera; Pfizer, New York City). While she is on time for this shot, she was late for two such appointments in the previous year. What if there was a contraceptive injection that your patients could be instructed to use in self-injection?
-
-
Oral rofecoxib (Vioxx) may have a role in controlling postoperative pain patients undergoing knee surgery.
-
This monograph provides an overview of allergic disorders and reviews the current understanding of the mechanism of the allergic response. Due to the extensive nature of the topic, the discussion has been limited to systemic reactions eliciting an IgE-mediated response. Further, the intimate relationship between organs involved is reviewed, particularly the relationship between allergic rhinitis and asthma.
-
Review the contraceptive options you currently discuss with your female patients. Where does natural family planning enter into the conversation? You may want to include a discussion of the Standard Days Method (SDM). Defined as a fertility-awareness-based method, the SDM is appropriate for women with regular menstrual cycles between 26 and 32 days long. It identifies days 8-19 of the menstrual cycle as the fertile window the days when pregnancy is very likely.
-
Many women may experience excessive menstrual bleeding, but for those with extreme menstrual bleeding (menorrhagia), such blood loss often interferes with daily activities and can lead to anemia. Defined as total menstrual blood loss of more than 80 ml/cycle, menorrhagia affects 15%-20% of American women.As a clinician, you may opt to treat menorrhagia with nonsteroidal anti-inflammatory drugs, progestins, or oral contraceptives. However, if these approaches prove ineffective, women may seek endometrial resection or ablation or undergo a hysterectomy
-
Does advance access to emergency contraception (EC) in adolescents lead to an increase in unprotected sex? Not according to findings from a newly published study, which indicate advance EC provision does not cause teens to have more unprotected intercourse or practice less consistent contraceptive use.
-
Get ready to implement new advances in your clinical setting: The Food and Drug Administration (FDA) has approved the use of oral fluid samples with a rapid HIV diagnostic test kit to provide accurate screening in as little as 20 minutes. While there are three rapid HIV testing kits now on the market, the OraQuick Rapid HIV Antibody Test is the first to get clearance for use on oral fluid samples, which bypasses the need for needlesticks or fingerpricks for blood samples.
